"A great match."
These are the chairman of Danish company Reapplix Ulrik Spork's words to describe the new US board member Richard Twomey, who, after six years working as the CEO in a leading medical solutions company, has agreed to advise and counsel the pharmaceutical firm on its path to success based on the company's biological band-aids for the treatment of diabetic foot ulcers.
Get full access for you and your coworkers.Start a free company trial today
Already a member? Log in.